Janus Henderson Group PLC Myovant Sciences Ltd. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $66.7 Million - $75 Million	-2,776,683 Reduced 70.23%	1,177,158 $31.7 Million
Q3 2022 Nov 14, 2022	SELL	$11.6 - $20.44 $17.3 Million - $30.6 Million	-1,495,266 Reduced 27.44%	3,953,841 $71 Million
Q2 2022 Aug 15, 2022	SELL	$7.78 - $14.69 $963,140 - $1.82 Million	-123,797 Reduced 2.22%	5,449,107 $67.7 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $16.4 $517,107 - $745,215	45,440 Added 0.82%	5,572,904 $74.2 Million
Q4 2021 Feb 14, 2022	SELL	$14.31 - $23.87 $2.17 Million - $3.62 Million	-151,586 Reduced 2.67%	5,527,464 $86.1 Million
Q3 2021 Nov 16, 2021	BUY	$18.94 - $26.99 $4.89 Million - $6.96 Million	258,033 Added 4.76%	5,679,050 $127 Million
Q2 2021 Aug 16, 2021	BUY	$17.07 - $24.56 $3.1 Million - $4.46 Million	181,735 Added 3.47%	5,421,017 $123 Million
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $2.88 Million - $3.55 Million	140,967 Added 2.76%	5,239,282 $108 Million
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $15.7 Million - $31.3 Million	1,134,832 Added 28.63%	5,098,315 $141 Million
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $951,423 - $1.53 Million	-67,717 Reduced 1.68%	3,963,483 $55.7 Million
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $5.01 Million - $14.2 Million	-682,289 Reduced 14.48%	4,031,200 $83.1 Million
Q1 2020 May 14, 2020	SELL	$6.55 - $14.76 $40,203 - $90,596	-6,138 Reduced 0.13%	4,713,489 $35.6 Million
Q4 2019 Feb 18, 2020	BUY	$4.2 - $19.21 $385,740 - $1.76 Million	91,843 Added 1.98%	4,719,627 $73.2 Million
Q3 2019 Nov 14, 2019	BUY	$5.19 - $9.46 $1.44 Million - $2.62 Million	277,449 Added 6.38%	4,627,784 $24.1 Million
Q2 2019 Jul 31, 2019	BUY	$8.69 - $25.0 $16 Million - $46.1 Million	1,843,943 Added 73.57%	4,350,335 $39.4 Million
Q1 2019 Apr 30, 2019	SELL	$16.83 - $24.45 $970,653 - $1.41 Million	-57,674 Reduced 2.25%	2,506,392 $59.8 Million
Q4 2018 Feb 06, 2019	BUY	$15.01 - $25.2 $583,483 - $979,599	38,873 Added 1.54%	2,564,066 $42.1 Million
Q3 2018 Nov 09, 2018	BUY	$19.33 - $26.78 $27.1 Million - $37.5 Million	1,401,796 Added 124.78%	2,525,193 $67 Million
Q2 2018 Aug 10, 2018	BUY	$19.2 - $25.14 $21.6 Million - $28.2 Million	1,123,397 New	1,123,397 $25.7 Million

Others Institutions Holding MYOV

# of Institutions

Shares Held

61.3K

Call Options Held

Put Options Held

View Full List

About Myovant Sciences Ltd.

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

More about MYOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account